DOAC

ESC 22: 3 Trials That Will Change Your Practice With Dr Afzal Sohaib

Afzal Sohaib,

Watch time: 3m 29s
ESC 22: APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID

Renato D Lopes,

Watch time: 3m 57s
ESC 22: ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19

Sanjit Jolly,

Watch time: 4m 59s
ESC 22: Milvexian in Addition to Aspirin ＆ Clopidogrel for Secondary Stroke

Mukul Sharma,

Watch time: 6m 26s
ESC 22: Dosing of Asundexian in Pts With Non-Cardioembolic Ischemic Stroke

Ashkan Shoamanesh,

Watch time: 7m 9s
ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Sotiris Antoniou , Bernard Man Yung Cheung, Krzysztof Filipiak, et al

Watch time: 6h 2m 18s (6 videos)
ACC 22: ADAPT-TAVR Shows SLT Does Not Affect CO for Patients After TAVR

Duk-Woo Park,

Watch time: 7m 44s
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

Watch time: 6m 33s

Daniel TT Chong , Felicita Andreotti , Peter Verhamme , et al

Julia Sikorska , James Uprichard ,

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Daniel TT Chong , Felicita Andreotti , Peter Verhamme , et al

Sotiris Antoniou , Bernard Man Yung Cheung, Krzysztof Filipiak, et al

Watch time: 6h 2m 18s (6 videos)
View from the Thoraxcenter: ESC 22 Late-breaking Science Preview

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 24m 27s

Antoni Martínez-Rubio , Mario DiazNuila-Alcazar , Anna Soria Cadena , et al

ESC 22 Late-breaker Discussion: The INVICTUS Trial

Harriette Van Spall, Ganesan Karthikeyan,

Watch time: 17m 13s

Emmanuel Sorbets , Philippe Gabriel Steg ,

Carina Blomström-Lundqvist , Helmut Pürerfellner , Alex White , et al

Antoni Martínez-Rubio , Gheorghe-Andrei Dan ,

ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

Watch time: 6m 33s

Mahmoud Abdelnabi , Abdallah Almaghraby , Yehia Saleh ,

Media

Doreen Su-Yin Tan, Gheorghe-Andrei Dan, Oskars Kalējs, et al

Watch time: 1h 1m 55s

Ignacio Cruz, Jens Erik Nielsen Kudsk, Prof Henning Ebelt, et al

Watch time: 2h 5m 51s

Pablo Avanzas, Román Freixa Pamias, Antoni Martínez-Rubio, et al

Watch time: 28m 4s
ESC 22: APOLLO: Apixaban for Prevention of Thromboembolic Outcomes in COVID

Renato D Lopes,

Watch time: 3m 57s
ESC 22: ACT: Anti-Coronavirus Therapies to Prevent Progression of COVID-19

Sanjit Jolly,

Watch time: 4m 59s

Sotiris Antoniou , Bernard Man Yung Cheung, Krzysztof Filipiak, et al

Watch time: 6h 2m 18s (6 videos)
Dual Antithrombotic Therapy With Dabigatran

Christopher P Cannon,

Watch time: 5m 44s
View from the Thoraxcenter - What's hot at ESC 2019

Nicolas M Van Mieghem, Joost Daemen,

Watch time: 18m 17s
AHA 2019: Updates from GALILEO-4D

Ole De Backer,

Watch time: 4m 8s
ESC 2020: Edoxaban for Elderly AF Patients — Dr Ken Okumura

Ken Okumura,

Watch time: 8m 16s
TCT Connect 2020 Discussion: The VOYAGER PAD Study

Mirvat Alasnag, ,

Watch time: 17m 13s
ENVISAGE-TAVI AF: Edoxaban noninferior to warfarin for adverse events after TAVI

George D Dangas,

Watch time: 6m 33s

Articles

APSC Consensus Recommendations on DOACs in Asian Patients with AF

Daniel TT Chong

,

Felicita Andreotti

,

Peter Verhamme

,

Jamshed J Dalal

,

Noppacharn Uaprasert

,

Chun-Chieh Wang

,

Young Keun On

,

Yi-Heng Li

,

Jun Jiang

,

Koji Hasegawa

,

Khalid Almuti

,

Rong Bai

,

Sidney TH Lo

,

Rungroj Krittayaphong

,

Lai Heng Lee

,

David Quek

,

Sofian Johar

,

Seow Swee Chong

,

Christopher J Hammett

,

Jack Wei Chieh Tan

,

Published:

28 May 2021

Citation:

European Cardiology Review 2021;16:e23.

DOI:

https://doi.org/10.15420/ecr.2020.43
  • Views: Views 3337
  • Downloads: Downloads 226
  • Citations: 10

Redefining the Standard for Atrial Fibrillation: A Patient-centric Report

Carina Blomström-Lundqvist

,

Helmut Pürerfellner

,

Alex White

,

Richard Schilling

,

Published:

25 February 2021

Citation:

European Cardiovascular Review 2021;16(Suppl 1):1–6.

DOI:

https://doi.org/10.15420/ecr.2021.16.s1
  • Views: Views 827
  • Downloads: Downloads 29

Will Direct Oral Anticoagulants Have a Chance in Prosthetic Valves?

Mahmoud Abdelnabi

,

Abdallah Almaghraby

,

Yehia Saleh

,

Published:

26 February 2020

Citation:

European Cardiology Review 2020;15:e06.

DOI:

https://doi.org/10.15420/ecr.2019.1.3
  • Views: Views 665
  • Downloads: Downloads 20
  • Citations: 4

DOACs in Chronic Coronary Syndromes

Emmanuel Sorbets

,

Philippe Gabriel Steg

,

Published:

26 February 2020

Citation:

European Cardiology Review 2020;15:e10.

DOI:

https://doi.org/10.15420/ecr.2018.24.2
  • Views: Views 893
  • Downloads: Downloads 61
  • Citations: 2